DK0626177T3 - Ernæring til personer inficeret med humant immundefekt-virus - Google Patents

Ernæring til personer inficeret med humant immundefekt-virus

Info

Publication number
DK0626177T3
DK0626177T3 DK93114404T DK93114404T DK0626177T3 DK 0626177 T3 DK0626177 T3 DK 0626177T3 DK 93114404 T DK93114404 T DK 93114404T DK 93114404 T DK93114404 T DK 93114404T DK 0626177 T3 DK0626177 T3 DK 0626177T3
Authority
DK
Denmark
Prior art keywords
immunodeficiency virus
human immunodeficiency
infected
nutritional product
person
Prior art date
Application number
DK93114404T
Other languages
Danish (da)
English (en)
Inventor
Frederick Oliver Cope
Normanella Torres Dewille
Ernest William Richards
Bonnie Chandler Abbruzzese
Michael Allen Chandler
Gregory Allan Snowden
Terrence Bruce Mazer
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/069,264 external-priority patent/US5330972A/en
Priority claimed from US08/069,269 external-priority patent/US5403826A/en
Priority claimed from US08/069,066 external-priority patent/US5480872A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0626177T3 publication Critical patent/DK0626177T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pediatric Medicine (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK93114404T 1993-05-28 1993-09-08 Ernæring til personer inficeret med humant immundefekt-virus DK0626177T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/069,264 US5330972A (en) 1993-05-28 1993-05-28 Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus
US08/069,269 US5403826A (en) 1993-05-28 1993-05-28 Nutritional product for persons infected with human immunodeficiency virus
US08/069,066 US5480872A (en) 1993-05-28 1993-05-28 Method of providing enternal nutritional support to persons infected with human immunodeficiency virus

Publications (1)

Publication Number Publication Date
DK0626177T3 true DK0626177T3 (da) 2000-05-08

Family

ID=27371464

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93114404T DK0626177T3 (da) 1993-05-28 1993-09-08 Ernæring til personer inficeret med humant immundefekt-virus

Country Status (15)

Country Link
EP (1) EP0626177B1 (de)
JP (1) JPH089545B2 (de)
KR (1) KR970005330B1 (de)
AT (1) ATE187076T1 (de)
AU (1) AU651284B1 (de)
CA (1) CA2105790C (de)
DE (1) DE69327159T2 (de)
DK (1) DK0626177T3 (de)
ES (1) ES2142842T3 (de)
GR (1) GR3032748T3 (de)
IL (1) IL106975A (de)
NZ (1) NZ248603A (de)
PH (1) PH30682A (de)
PT (1) PT626177E (de)
TW (1) TW492867B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
US5759548A (en) * 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
EP0850064A1 (de) * 1995-09-14 1998-07-01 Lxr Biotechnology Inc. Anti-apoptose zusammensetzung die eine mischung von phospholipiden enthält
US5681600A (en) * 1995-12-18 1997-10-28 Abbott Laboratories Stabilization of liquid nutritional products and method of making
US5981587A (en) * 1996-07-31 1999-11-09 Abbott Laboratories Water-miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection
US5958974A (en) * 1996-07-31 1999-09-28 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as antibacterial agents
US5866606A (en) * 1996-07-31 1999-02-02 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as anti-microbial agents
CA2257412A1 (en) * 1996-07-31 1998-02-05 Abbott Laboratories Water-miscible esters of monoglycerides having antimicrobial activity
US5908862A (en) * 1996-07-31 1999-06-01 Abbot Laboratories Water-miscible esters of mono--and diglycerides having antibacterial activity and their use in inhibiting infection
US6495532B1 (en) 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6200950B1 (en) * 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
US6194379B1 (en) 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
US6413556B1 (en) 1999-01-08 2002-07-02 Sky High, Llc Aqueous anti-apoptotic compositions
EP1236405B1 (de) * 2001-03-01 2006-06-21 Societe Des Produits Nestle S.A. Hypoallergene Nahrungsmittel zur Induzierung oraler Toleranz gegenüber Sojaproteinen
EP1281325A1 (de) * 2001-07-30 2003-02-05 Societe Des Produits Nestle S.A. Ernährungszusammensetzung zur Unterdrückung von bakteriellem Wachstum
JP4554149B2 (ja) * 2002-11-28 2010-09-29 雅美 森山 レトロウイルス感染症治療薬
WO2005023018A1 (en) * 2003-09-10 2005-03-17 Unilever N.V. Food composition
EP1723951A1 (de) † 2005-04-21 2006-11-22 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
CA2570208A1 (en) * 2004-06-22 2005-12-29 N.V. Nutricia Improvement of barrier integrity in hiv patients
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
JP5098198B2 (ja) * 2005-03-28 2012-12-12 大正製薬株式会社 銅化合物配合組成物
WO2007063141A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Producto alimenticio para la nutrición por vía enteral u oral
WO2007063143A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Mezcla de lipidos y su utilización para preparar un producto destinado a la adminitracion enteral u oral
WO2007063142A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Mezcla de proteínas y su utilización para preparar un producto destinado a la alimentación oral o enteral
US20090208598A1 (en) * 2006-01-31 2009-08-20 Parsroos Co. Use of a combination of ethanolic rosa sp., urtica dioica and tanacetum vulgare extracts, further compromising selenium and urea and having been exposed to a pulsed electromagnetic field, for the preparation of a medicament for immunostimulation and/or treatment of hiv infections
JP5181486B2 (ja) * 2006-02-16 2013-04-10 大正製薬株式会社 亜鉛化合物配合経口用組成物
JP2007246509A (ja) * 2006-02-16 2007-09-27 Taisho Pharmaceut Co Ltd 銅化合物配合経口用組成物
CA2735153A1 (en) * 2008-10-10 2010-04-15 Solae, Llc High caloric enteral formulations
WO2016035095A1 (en) * 2014-09-01 2016-03-10 Vadakkemuri Mathew Jolly Optimized nutrient food

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3680346D1 (de) * 1985-01-29 1991-08-29 Abbott Lab Enterales hypoallergenisches ernaehrungsrezept.
SE8601828D0 (sv) * 1986-04-21 1986-04-21 Novo Industri As Enteral diet product and agent for production thereof
DE3785667T2 (de) * 1986-09-17 1994-07-21 Clintec Nutrition Co Zusatznahrung bzw. therapie für personen mit risiko oder in behandlung für arteriosklerotische vaskuläre, kardiovaskuläre und/oder thrombotische erkrankungen.
DK3991D0 (da) * 1991-01-10 1991-01-10 Novo Nordisk As Fremgangsmaade til fremstilling af et proteinhydrolysat
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat

Also Published As

Publication number Publication date
ATE187076T1 (de) 1999-12-15
KR970005330B1 (ko) 1997-04-15
EP0626177A3 (de) 1995-02-22
PT626177E (pt) 2000-05-31
EP0626177B1 (de) 1999-12-01
GR3032748T3 (en) 2000-06-30
ES2142842T3 (es) 2000-05-01
AU651284B1 (en) 1994-07-14
NZ248603A (en) 1994-12-22
EP0626177A2 (de) 1994-11-30
IL106975A0 (en) 1993-12-28
DE69327159T2 (de) 2000-07-13
JPH089545B2 (ja) 1996-01-31
CA2105790A1 (en) 1994-11-29
DE69327159D1 (de) 2000-01-05
PH30682A (en) 1997-09-16
CA2105790C (en) 1998-07-28
IL106975A (en) 1996-01-19
TW492867B (en) 2002-07-01
JPH06340545A (ja) 1994-12-13

Similar Documents

Publication Publication Date Title
DK0626177T3 (da) Ernæring til personer inficeret med humant immundefekt-virus
BR9712259A (pt) Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.
BR9105986A (pt) Formulacao de liberacao por tempo de vitaminas,minerais e outros suplementos beneficos
DE69331528T2 (de) Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
DE69026496D1 (de) Analoge von vitamin a und ihre verwendung, insbesondere als cytotrophische und cytoprotective substanzen sowie diese substanzen enthaltende arzneimittel
DK0626176T3 (da) Næringsmiddel til personer, som undergår stråleterapi eller kemoterapi
ATE88631T1 (de) Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
DE68924429D1 (de) Diät zur besserem Ueberleben von Kranken mit Sepsis.
CA2094275A1 (en) Methods and compositions for the treatment of cell proliferation disorders
WO1988003150A3 (fr) Preparations aminoacides contenant des peptides de n,n'-bis-l-aminoacide-l-cystine et destinees a l'administration orale et parenterale
ATE178615T1 (de) Verwendung eines dekapeptids mit benzodiazepinischer wirkung zur herstellung von arzneimitteln und diätzusätzen
McBride Agnotes: Don't Overdo the Vitamin A
Guembel Change of arachidonic acid and docosa-hexaen acid speculum in the serum of people having heart trouble on a coronary diet with mackerel.).
IT8920225A0 (it) Integratori dietetici, in particolare per condizioni di accresciuto catabolismo proteico.
TH13901EX (th) ผลไม้ประดิษฐ์
TH13897EX (th) ผลไม้ประดิษฐ์
TH13906EX (th) ผลไม้ประดิษฐ์
TH13907EX (th) ผลไม้ประดิษฐ์
TH13904EX (th) ผลไม้ประดิษฐ์
TH13903EX (th) ผลไม้ประดิษฐ์
TH13908EX (th) ผลไม้ประดิษฐ์
TH13900EX (th) ผลไม้ประดิษฐ์
TH13909EX (th) ผลไม้ประดิษฐ์
TH13894EX (th) ผลไม้ประดิษฐ์
TH13898EX (th) ผลไม้ประดิษฐ์